-
Gemphire Flirts With $1 Level As Struggling Biotech Strikes Reverse Merger Deal
Thursday, July 25, 2019 - 10:15am | 530Read More...Gemphire Therapeutics Inc (NASDAQ: GEMP) stock — which has been on a broader downtrend since mid-2017 — was advancing strongly Thursday. The stock has been under pressure amid some clinical trial setbacks, and has been trading in penny stock territory since late May. The...
